INSMED INC (1INSM.MI) Stock Fundamental Analysis

BIT:1INSM • US4576693075

127 EUR
-6 (-4.51%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

1INSM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 78 industry peers in the Biotechnology industry. 1INSM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1INSM is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year 1INSM has reported negative net income.
  • 1INSM had a negative operating cash flow in the past year.
  • 1INSM had negative earnings in each of the past 5 years.
  • In the past 5 years 1INSM always reported negative operating cash flow.
1INSM.MI Yearly Net Income VS EBIT VS OCF VS FCF1INSM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M -800M

1.2 Ratios

  • With a Return On Assets value of -50.15%, 1INSM is not doing good in the industry: 62.82% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -125.20%, 1INSM is in line with its industry, outperforming 47.44% of the companies in the same industry.
Industry RankSector Rank
ROA -50.15%
ROE -125.2%
ROIC N/A
ROA(3y)-43.52%
ROA(5y)-40.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1INSM.MI Yearly ROA, ROE, ROIC1INSM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • 1INSM has a Gross Margin of 76.54%. This is in the better half of the industry: 1INSM outperforms 66.67% of its industry peers.
  • 1INSM's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 1INSM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.05%
GM growth 5Y-1.46%
1INSM.MI Yearly Profit, Operating, Gross Margins1INSM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • 1INSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1INSM has more shares outstanding
  • The number of shares outstanding for 1INSM has been increased compared to 5 years ago.
  • 1INSM has a better debt/assets ratio than last year.
1INSM.MI Yearly Shares Outstanding1INSM.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1INSM.MI Yearly Total Debt VS Total Assets1INSM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 9.92 indicates that 1INSM is not in any danger for bankruptcy at the moment.
  • 1INSM has a better Altman-Z score (9.92) than 87.18% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that 1INSM is somewhat dependend on debt financing.
  • 1INSM has a Debt to Equity ratio (0.77) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 9.92
ROIC/WACCN/A
WACC8.42%
1INSM.MI Yearly LT Debt VS Equity VS FCF1INSM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

  • 1INSM has a Current Ratio of 4.63. This indicates that 1INSM is financially healthy and has no problem in meeting its short term obligations.
  • 1INSM has a Current ratio of 4.63. This is in the better half of the industry: 1INSM outperforms 78.21% of its industry peers.
  • A Quick Ratio of 4.34 indicates that 1INSM has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 4.34, 1INSM is in the better half of the industry, outperforming 79.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.63
Quick Ratio 4.34
1INSM.MI Yearly Current Assets VS Current Liabilites1INSM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • 1INSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.53%.
  • 1INSM shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.34%.
  • The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-11.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.8%
Revenue 1Y (TTM)30.34%
Revenue growth 3Y24.49%
Revenue growth 5Y21.65%
Sales Q2Q%52.36%

3.2 Future

  • 1INSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.61% yearly.
  • Based on estimates for the next years, 1INSM will show a very strong growth in Revenue. The Revenue will grow by 70.00% on average per year.
EPS Next Y-9.24%
EPS Next 2Y20.55%
EPS Next 3Y24.84%
EPS Next 5Y28.61%
Revenue Next Year55.07%
Revenue Next 2Y93.53%
Revenue Next 3Y87.53%
Revenue Next 5Y70%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1INSM.MI Yearly Revenue VS Estimates1INSM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B 10B
1INSM.MI Yearly EPS VS Estimates1INSM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • 1INSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year 1INSM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1INSM.MI Price Earnings VS Forward Price Earnings1INSM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1INSM.MI Per share data1INSM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1INSM's earnings are expected to grow with 24.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.55%
EPS Next 3Y24.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1INSM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSMED INC

BIT:1INSM (2/16/2026, 7:00:00 PM)

127

-6 (-4.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners99.83%
Inst Owner ChangeN/A
Ins Owners0.59%
Ins Owner ChangeN/A
Market Cap27.09B
Revenue(TTM)447.02M
Net Income(TTM)-1.18B
Analysts85.19
Price Target186.48 (46.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.48%
Min EPS beat(2)-28.87%
Max EPS beat(2)-28.09%
EPS beat(4)0
Avg EPS beat(4)-18.15%
Min EPS beat(4)-28.87%
Max EPS beat(4)-4.46%
EPS beat(8)1
Avg EPS beat(8)-14.89%
EPS beat(12)2
Avg EPS beat(12)-15.58%
EPS beat(16)4
Avg EPS beat(16)-11.73%
Revenue beat(2)2
Avg Revenue beat(2)11.07%
Min Revenue beat(2)1.43%
Max Revenue beat(2)20.71%
Revenue beat(4)2
Avg Revenue beat(4)5.14%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)20.71%
Revenue beat(8)3
Avg Revenue beat(8)1.76%
Revenue beat(12)4
Avg Revenue beat(12)1.09%
Revenue beat(16)6
Avg Revenue beat(16)1.62%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)4.21%
EPS NY rev (1m)-8.65%
EPS NY rev (3m)-8.65%
Revenue NQ rev (1m)43.26%
Revenue NQ rev (3m)43.26%
Revenue NY rev (1m)18.95%
Revenue NY rev (3m)18.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 71.21
P/FCF N/A
P/OCF N/A
P/B 33.67
P/tB 43.92
EV/EBITDA N/A
EPS(TTM)-5.27
EYN/A
EPS(NY)-2.6
Fwd EYN/A
FCF(TTM)-3.62
FCFYN/A
OCF(TTM)-3.52
OCFYN/A
SpS1.78
BVpS3.77
TBVpS2.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -50.15%
ROE -125.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.54%
FCFM N/A
ROA(3y)-43.52%
ROA(5y)-40.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.05%
GM growth 5Y-1.46%
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.18%
Cap/Sales 5.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.63
Quick Ratio 4.34
Altman-Z 9.92
F-Score3
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)113.37%
Cap/Depr(5y)86.53%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.8%
EPS Next Y-9.24%
EPS Next 2Y20.55%
EPS Next 3Y24.84%
EPS Next 5Y28.61%
Revenue 1Y (TTM)30.34%
Revenue growth 3Y24.49%
Revenue growth 5Y21.65%
Sales Q2Q%52.36%
Revenue Next Year55.07%
Revenue Next 2Y93.53%
Revenue Next 3Y87.53%
Revenue Next 5Y70%
EBIT growth 1Y-40.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-34.1%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-72.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.7%
OCF growth 3YN/A
OCF growth 5YN/A

INSMED INC / 1INSM.MI FAQ

Can you provide the ChartMill fundamental rating for INSMED INC?

ChartMill assigns a fundamental rating of 3 / 10 to 1INSM.MI.


Can you provide the valuation status for INSMED INC?

ChartMill assigns a valuation rating of 1 / 10 to INSMED INC (1INSM.MI). This can be considered as Overvalued.


Can you provide the profitability details for INSMED INC?

INSMED INC (1INSM.MI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for 1INSM stock?

The Earnings per Share (EPS) of INSMED INC (1INSM.MI) is expected to decline by -9.24% in the next year.